Nvidia lost ~$1T in market value in less than two months, dropping 16% from its May all-time-high, trading at 18x forward earnings, its lowest level since 2019
After losing roughly $1 trillion in market value in less than two months, Nvidia Corp.'s stock is the cheapest it's been since …
Context & Ripple Effects
This is the latest in a series of sharp Nvidia selloffs: related coverage records a 10% decline in April 2024, a 9.5% decline in September 2024, and a 16.86% one-day fall in January 2025. The earlier reports explicitly tied the pullbacks to investors tempering AI optimism.
The current move matters because it extends that recurring volatility into a sustained valuation reset: Nvidia is now described as trading at its lowest forward-earnings multiple since 2019, despite its central place in AI-chip market narratives.
First-order effects
- Nvidia shareholders have absorbed roughly $1 trillion in lost market value in under two months, with the stock 16% below its May peak.
- The company’s forward valuation multiple has compressed to 18x, reducing the market premium investors are willing to assign to its expected earnings.
Second-order effects
- A lower multiple raises the burden on Nvidia’s future results and AI-product execution to sustain investor confidence, rather than allowing valuation expansion to carry returns.
- The move reinforces scrutiny of AI-linked equities more broadly: prior Nvidia declines were associated with softer investor optimism about AI, making the stock a focal point for sentiment toward the sector.
Third-order effects
- If repeated valuation resets persist, AI hardware may be treated less as a single momentum trade and more as a cyclical market where growth expectations are regularly repriced.
- The pattern suggests that leadership in AI chips does not insulate a company from abrupt changes in the cost of equity capital; whether this becomes durable depends on subsequent earnings and demand evidence not provided here.
The trend: The larger trend is the normalization of AI-market expectations, in which even leading chip suppliers face recurring repricing as investors test growth narratives against valuation.